Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 563, pseudogene (RN7SL563P)
- Target
- RN7SL563P
- Molecular classification
- Pseudogene, noncoding RNA, processed pseudogene
01
Overview
RN7SL563P is a human pseudogene related to the functional 7SL RNA, which is an essential component of the signal recognition particle (SRP) involved in protein targeting to membranes. Like other 7SL pseudogenes, RN7SL563P is a truncated reverse transcription-derived genomic copy of 7SL RNA, dispersed in the genome and generally not expressed at detectable levels. Pseudogenes such as RN7SL563P can sometimes produce noncoding RNAs with potential regulatory activity, but no direct function has been attributed to this locus. Unlike the functional 7SL RNA, which participates in protein translocation and may influence cell translation or p53 signaling in cancer, RN7SL563P is not therapeutically actionable and lacks established biological or disease associations.
- Other names
- RN7SL563PRNA, 7SL, cytoplasmic 563, pseudogene
02
Mechanism of action
Not applicable; no known drugs or direct mechanism of action
03
Biological functions
May produce small RNAs (sRNAs) or noncoding transcriptsMay act as a competing endogenous RNA (ceRNA) or microRNA sponge, potentially weakly regulating parental gene expressionNo canonical biological function established
04
Disease associations
None established for RN7SL563P specificallyNo evidence for involvement in cancer, inflammation, infection, or other diseases
05
Safety considerations
None. As a pseudogene, RN7SL563P poses no known safety concerns or therapeutic challenges
06
Interacting drugs
None known or reported. Pseudogenes, including RN7SL563P, are not conventional drug targets
07
Biomarkers
None. RN7SL563P is not used as a clinical biomarker for patient selection or efficacy monitoring
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 563, pseudogene (RN7SL563P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 563, pseudogene (RN7SL563P).